medigraphic.com
ISSN 1561-3062 (Electronic)

2017, Number 1

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2017; 43 (1)

Intensity and evolution of the climacteric syndrome and its relation with atherosclerosis risk factors

Lugones BMÁ, Navarro DD, Fernández Britto-Rodríguez JE, Bacallao GJ

Language: Spanish
References: 47
Page: 1-16
PDF size: 185.10 Kb.


ABSTRACT

Introduction: The study of climacteric and menopause has great importance and validity due to its associated morbidity.
Objective: Determine the presence of atherosclerotic risk factors with the intensity and evolution of the climacteric syndrome in this group.
Methods: A prospective and interventional study was carried out in women aged 40 to 59 years with climacteric syndrome who received hormone therapy - previous informed consent. The evolutionary response was observed.
Results: The variables studied (overweight, obesity, sedentary lifestyle, smoking habits, waist circumference, arterial hypertension and type 2 diabetes mellitus), these women gender overload were related to the presence and unfavorable evolution of the climacteric syndrome. Obesity and overweight are the most influential on this syndrome evolution. The other major variable was smoking. In order of importance, sedentary followed.
Conclusions: The atherosclerosis risk factors studied were associated with a more intense climacteric syndrome and with an unfavorable evolution of them, which is the scientific contribution of this research. Increased waist circumference, high body mass index and smoking habits were the most important risk factors for the unfavorable evolution of this syndrome.


REFERENCES

  1. Lugones BM. La salud de la mujer en el climaterio y la menopausia. La Habana: Científico Técnica; 2006:5-7.

  2. Colectivo de autores. II Consenso Cubano de Climaterio y Menopausia. Editorial CIMEQ. 2007:15-58. [citado 17 de setiembre de 2016]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/ginecobs/consenso2006seccclimymenop.pdf

  3. Zárate A. Longevidad y Menopausia. En su: Menopausia y cerebro. Aspectos psicosociales y neurohormonales de la mujer climatérica. México: Editorial Trillas; 1997. p. 1-13.

  4. Manzano OB. Prólogo. En: Lugones BM: La salud de las mujer en el climaterio y la menopausia. La Habana: Científico Técnica; 2006: XI.

  5. Shetty KD, Vogt WB, Bhattacharya J. Hormone replacement therapy and cardiovascular health in the United States. Med Care. 2009;47:600-6.

  6. Ochoa MLA. Muerte súbita cardíaca en comunidades de Arroyo Naranjo en el período 2000-2010. [Tesis de doctorado]. La Habana: falta la ciudad; 2012. [citado 17 de septiembre de 2016]. Disponible en: http://tesis.repo.sld.cu/639/

  7. Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther. 2012;10:933-9.

  8. Topatan S, Yıldız H. Symptoms experienced by women who enter into natural and surgical menopause and their relation to sexual functions. Health Care Women Int. 2012;33(6):525-39.

  9. Perkins AE. Dangers of the menopause. Am J Nurs. 2012 Jun;112(6):68-9.

  10. Burger HG, Maclennan AH, Huang KE, Castelo-Branco C: Evidence-based assessment of the impact of the WHI on women's health. Climacteric. 2012;15(3):281-7.

  11. Maggio Da Fonseca A, Bagnoli VR, Souza MA, Azevedo RS, Couto Júnior Ede B, Soares Júnior JM, et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol. 2013 Feb;29(2):116-8.

  12. Greenblum CA, Rowe MA, Neff DF, Greenblum JS. Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life. Menopause. 2013;20(1):22-7.

  13. Williams RE, Kalilani L, Bibenedetti DB, Zhou X. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11:32-43.

  14. Archer DF, Pickar JH, Macallister DC, Warren MP. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women. Menopause. 2012;19(6):622-9.

  15. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM. American Heart Association. Hormone Replacement Therapy and Cardiovascular Disease: A statement for Healthcae Professionals from the American Heart Association. Circulation. 2012;113(4):499-503.

  16. Thurston RC, Christie IC, Matthews KA. Hot flashes and cardiac vagal control during women's daily lives. Menopause. 2012 Apr;19(4):406-12.

  17. Oficina Nacional de Estadísticas e Información. Anuario Estadístico de Cuba. 2013; Edición 2014:5-6.

  18. Palacios S. Peso y distribución grasa en la mujer posmenopáusica. Rev Iberoam Menop. 2008;7(1):2.

  19. Suzuki S, Kojima M, Tokudome S, Mori M, Sakauchi F, Wakai K, et al. Obesity/Weight Gain and Breast Cancer Risk: Findings From the Japan Collaborative Cohort Study for the Evaluation of Cancer Risk. J Epidemiol. 2013.

  20. Coutinho T, Kashish G, Corrêa de Sá D, Charlotte Kragelund Ch, Alka M, Kanaya AM, et al. Central Obesity and Survival in Subjects With Coronary Artery Disease. J Am Coll Cardiol. 2011;57:1887-9.

  21. Ascaso JF. Obesidad abdominal y riesgo metabólico y vascular. Med Clin (Barc). 2008;131:380-1.

  22. Lambrinoudaki I: Cardiovascular risk in postmenopausal. Maturitas. 2011;68(1):13-6.

  23. Von Helde S, Cifuentes I, Palacios S. Influencia de la terapia hormonal de reemplazo en el peso y la distribución grasa corporal. Rev Iberoam Menop. 2001;3(1):13-17.

  24. Krauss RM, Winston M, Fletcher RN, Grundy SM. Obesity: impact of cardiovascular disease. Circulation. 1998;98:1472-6.

  25. Hoikkala H, Haapalahti P, Viitasalo M: Association between vasomotor hot flashes and heart rate variability in recently postmenopausal women. Menopause. 2010;17:315-20.

  26. Huang AJ, Subak L, Wing R, West DS, Hernández AL, Macer J, et al. An Intensive Behavioral Weight Loss Intervention and Hot Flushes in Women. Arch Intern Med. 2010;170(13):1161-7.

  27. Barreto SM, Miranda JJ, Figueroa JP, Schmidt MI, Sergio Munoz, Kuri-Morales S, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. International Journal of Epidemiology. 2012;41:557-71.

  28. Hernández MN, Anías CJ. Estrés. Rev Cubana Med Gen Integr. 1992;8(3):261-70

  29. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause. 2010;17:256-61.

  30. Arce Bustabad S. Inmunología clínica y estrés. En busca de la conexión perdida entre el alma y el cuerpo. La Habana: Ed. Científico Técnica. 2007:54.

  31. U. S. Department of Health and Human Services: A Report of the Surgeon General: How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. Rockville: Public Health Service, Office of the Surgeon General; 2010.

  32. Fernández Guerrero Ml, Muñoz Calero B, García-Rubira JC, López García-Aranda V. Tabaco y corazón. Programas actuales del control del hábito. Clin Invest Arterioscl. 2010;22:167-73.

  33. Roopinder K, Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, et al. Smoking, Smoking Cessation, and Risk of Sudden Cardiac Death in Women. Circ Arrhythm Electrophysiol. 2012;5:1091-7.

  34. Orzechowski W, Walker RC. The Tax Burden on Tobacco, 2012. Tables 9, 12, and 19. Arlington, VA: Orzechowski and Walker, 2013. 26-53.

  35. Kirkegaard H, Johnsen NF, Christensen J, Kirsten FJ, Overvad K, Tjønneland A: Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ 2010; 341:c5504.

  36. Ellekjaer H, Holmen J, Ellekjaer E, Vatten L. Physical activity and stroke mortality in women. Stroke. 2009;39:14-6.

  37. Domínguez-AE, Zacea E. Sistema de salud de Cuba. Salud pública Méx. 2011[citado 20 de septiembre de 2016];53(2) [revista en Internet]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036- 36342011000800012&lng=es

  38. Skrzypulec V, Dabrowska J, Drosdzol A. The influence of physical activity level on climacteric symptoms in menopausal women. Climacteric. 2011;13:355-61.

  39. Li S, Zhao JH, Luan J, Ekelund U, Luben RN. Physical Activity Attenuates the Genetic Predisposition to Obesity in 20,000 Men and Women from EPIC-Norfolk Prospective Population Study. PLoS Med. 2011;7(8):1371.

  40. Kunstmann S, de Grazia R, Gainza D. Aterosclerosis en la mujer: factores de riesgo y prevención. Chil Card. 2012 ago [citado 2014 oct];31(2):142-47. Disponible en: http://www.scielo.cl/scielo.php?pid=S0718- 85602012000200009&script=sci_arttext

  41. Zapata OG. Predicción temprana del riesgo en el infarto agudo de miocardio: una difícil tarea de todos los días. Editorial. Rev Fed Arg Cardiol. 2011;40(1):1-2.

  42. Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, Mezones-Holguín E. Barón G, Bencosme A, et al. Type II diabetes mellitus and menopause: a multinational study. Climacteric. 2013;16:1-10.

  43. Manzano OB, Artiles VL, Navarro DD, Pérez PJ, Nodarse A. Modelo de Atención a la Mujer Climatérica (MACLI). Rev Cubana Obstet Ginecol. 1998[citado 20 de septiembre de 2016]:24(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 600X1998000200008&lng=es&nrm=iso&tlng=es

  44. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256-261.

  45. Guijarro C, García-Díaz JD. Estrategias terapéuticas. Evolución y estado actual de las Guías Europeas de Prevención Cardiovascular. Clin Invest Arterioscl. 2013;25(2):92-97.

  46. Villalba DR. Enfoque de riesgo. Aspectos conceptuales. Salud Comunitaria. 2013. [citado 29 de septiembre de 2016]. Disponible en: http://unvimesaludcomunitaria.blogspot.com/

  47. Fernández-Britto RJE. Editorial. Rev Haban Cienc Méd. 2012[citado 20 de septiembre de 2016];11(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=1729- 519X20120003&lng=es&nrm=iso




2020     |     www.medigraphic.com